The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

The Investment Committee give you their top stocks to watch for the second half.

Qatar's VC (venture capital) funding reported a remarkable 135% year-on-year rise to an all-time high of QR115mn in 2024, defying 19% and 29% decline ...

Malaysia’s position in the ongoing tariff dispute is rooted in ASEAN’s long-standing neutrality and multilateral engagement policy. Speaking in the Dewan Rakyat, Anwar emphasised that Malaysia remains ...

TrueFoundry, a startup offering enterprises a platform to deploy compound AI systems at scale, as raised $19 million in a ...

Google has released a whole new range of AI-powered research and interactions that simply can't be matched by DeepSeek or OpenAI.

Life Science Washington, the state’s life sciences industry association, announced the expansion of its board of directors with the ad ...

The global selloff is tearing through markets as traders headed for the exit following Trump’s tariff announcements.

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

Vertex Pharmaceuticals ( VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic ...

Vertex Minerals has initiated the commissioning of a newly installed ore sorter at its Hill End Gold plant in Australia.